Showing results (771-780 of 801) with videos related to

Sort By:
Pageof 81
The New England Journal of Medicine|January 31, 2024
CRISPR-Cas9 In Vivo Gene Editing of KLKB1 for Hereditary AngioedemaHilary J Longhurst, Karen Lindsay, Remy S Petersen, et al.
Clinical and Translational Allergy|November 18, 2025
Sebetralstat for On-Demand Treatment of Mucosal Hereditary Angioedema Attacks in KONFIDENT-SJonathan A Bernstein, Emel Aygören-Pürsün, Mauro Cancian, et al.
Lancet (London, England)|February 11, 2023
An investigational oral plasma kallikrein inhibitor for on-demand treatment of hereditary angioedema: a two-part, randomised, double-blind, placebo-controlled, crossover phase 2 trialEmel Aygören-Pürsün, Andrea Zanichelli, Danny M Cohn, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 5, 2026
Impact of Oral Sebetralstat on Anxiety Associated With Hereditary Angioedema AttacksTimothy Craig, Emel Aygören-Pürsün, Jonathan A Bernstein, et al.
Frontiers in Allergy|July 13, 2026
The Chronic Angioedema Registry: what the first 2 years since the implementation of the global registry have taught usThomas Buttgereit, Mathias Sulk, Jonathan A Bernstein, et al.
Allergy|January 30, 2026
International Guideline on the Diagnosis and Management of Pediatric Patients With Hereditary AngioedemaHenriette Farkas, Inmaculada Martinez-Saguer, Konrad Bork, et al.
The New England Journal of Medicine|May 31, 2024
Oral Sebetralstat for On-Demand Treatment of Hereditary Angioedema AttacksMarc A Riedl, Henriette Farkas, Emel Aygören-Pürsün, et al.
Clinical Reviews in Allergy & Immunology|March 7, 2025
Hereditary Angioedema with Normal C1 Inhibitor: an Updated International Consensus Paper on Diagnosis, Pathophysiology, and TreatmentBruce L Zuraw, Konrad Bork, Laurence Bouillet, et al.
The Journal of Allergy and Clinical Immunology. Global|April 25, 2025
Global frequency, diagnosis, and treatment of hereditary angioedema with normal C1 inhibitorMarkus Magerl, Marc A Riedl, Luisa Karla Arruda, et al.
Journal of Critical Care|August 3, 2024
Antisense therapy to block the Kallikrein-kinin pathway in COVID-19: The ASKCOV randomized controlled trialFernando G Zampieri, Glauco Adrieno Westphal, Maria Adelaide Dos Santos, et al.
Pageof 81